21
Participants
Start Date
May 2, 2019
Primary Completion Date
April 26, 2023
Study Completion Date
May 2, 2024
ctDNA analysis
Regular ctDNA analysis, which upon a decrease in mutant BRAF VAF (variant allele frequency) level of ≥80% the switch to N+I is triggered.
The Christie NHS Foundation Trust, Manchester
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of Manchester
OTHER
Manchester Academic Health Science Centre
OTHER
The Christie NHS Foundation Trust
OTHER